Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Pediatric drug-trial recruitment: enticement without coercion.

Tishler CL, Reiss NS.

Pediatrics. 2011 May;127(5):949-54. doi: 10.1542/peds.2010-2585. Epub 2011 Apr 4. Review.

PMID:
21464193
2.

View of physicians on and barriers to patient enrollment in a multicenter clinical trial: experience in a Japanese rural area.

Yanagawa H, Kishuku M, Akaike M, Azuma H, Irahara M.

Int Arch Med. 2010 Jun 4;3:7. doi: 10.1186/1755-7682-3-7.

3.

Understanding the relative roles of pharmacogenetics and ontogeny in pediatric drug development and regulatory science.

Leeder JS, Kearns GL, Spielberg SP, van den Anker J.

J Clin Pharmacol. 2010 Dec;50(12):1377-87. doi: 10.1177/0091270009360533. Epub 2010 Feb 11.

PMID:
20150527
4.

Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.

Froehlich TE, McGough JJ, Stein MA.

CNS Drugs. 2010 Feb;24(2):99-117. doi: 10.2165/11530290-000000000-00000. Review.

5.

Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers.

Lötsch J, von Hentig N, Freynhagen R, Griessinger N, Zimmermann M, Doehring A, Rohrbacher M, Sittl R, Geisslinger G.

Pharmacogenet Genomics. 2009 Jun;19(6):429-36.

PMID:
19514130
6.

UGT genotype may contribute to adverse events following medication with mycophenolate mofetil in pediatric kidney transplant recipients.

Prausa SE, Fukuda T, Maseck D, Curtsinger KL, Liu C, Zhang K, Nick TG, Sherbotie JR, Ellis EN, Goebel J, Vinks AA.

Clin Pharmacol Ther. 2009 May;85(5):495-500. doi: 10.1038/clpt.2009.3. Epub 2009 Feb 18.

PMID:
19225446
7.

Conducting clinical trials in pediatrics.

Macrae D.

Crit Care Med. 2009 Jan;37(1 Suppl):S136-9. doi: 10.1097/CCM.0b013e318192101f.

PMID:
19104213
8.

Ethnic differences in warfarin maintenance dose requirement and its relationship with genetics.

Schelleman H, Limdi NA, Kimmel SE.

Pharmacogenomics. 2008 Sep;9(9):1331-46. doi: 10.2217/14622416.9.9.1331. Review.

PMID:
18781859
9.

The pharmacogenomic era: promise for personalizing attention deficit hyperactivity disorder therapy.

Stein MA, McGough JJ.

Child Adolesc Psychiatr Clin N Am. 2008 Apr;17(2):475-90, xi-xii. doi: 10.1016/j.chc.2007.11.009. Review.

10.

Management of children with autism spectrum disorders.

Myers SM, Johnson CP; American Academy of Pediatrics Council on Children With Disabilities.

Pediatrics. 2007 Nov;120(5):1162-82. Epub 2007 Oct 29. Review.

PMID:
17967921
11.

Recent development in pharmacogenomics: from candidate genes to genome-wide association studies.

Grant SF, Hakonarson H.

Expert Rev Mol Diagn. 2007 Jul;7(4):371-93. Review.

PMID:
17620046
12.

National surveillance of emergency department visits for outpatient adverse drug events.

Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL.

JAMA. 2006 Oct 18;296(15):1858-66.

PMID:
17047216
13.

Pharmacogenetics, drug-metabolizing enzymes, and clinical practice.

Gardiner SJ, Begg EJ.

Pharmacol Rev. 2006 Sep;58(3):521-90. Review.

14.

Treatment guidelines for children and adolescents with bipolar disorder.

Kowatch RA, Fristad M, Birmaher B, Wagner KD, Findling RL, Hellander M; Child Psychiatric Workgroup on Bipolar Disorder.

J Am Acad Child Adolesc Psychiatry. 2005 Mar;44(3):213-35.

PMID:
15725966
15.
16.
17.

The genetic polymorphism of drug transporters: functional analysis approaches.

Ishikawa T, Tsuji A, Inui K, Sai Y, Anzai N, Wada M, Endou H, Sumino Y.

Pharmacogenomics. 2004 Jan;5(1):67-99. Review.

PMID:
14683421
18.

Factors to consider in determining the feasibility of randomized clinical trials.

Dainty K, Karlsson J; ISAKOS Scientific Committee.

Arthroscopy. 2003 Oct;19(8):882-4. Review.

PMID:
14551554
19.

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus.

Hesselink DA, van Schaik RH, van der Heiden IP, van der Werf M, Gregoor PJ, Lindemans J, Weimar W, van Gelder T.

Clin Pharmacol Ther. 2003 Sep;74(3):245-54.

PMID:
12966368
20.

Chronic renal failure after transplantation of a nonrenal organ.

Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, Arndorfer J, Christensen L, Merion RM.

N Engl J Med. 2003 Sep 4;349(10):931-40.

Supplemental Content

Support Center